Covered recipient · General Payments record
JAMES HENRY REED
General Payments · PY2018–2024
$2,187.48
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $210.52 | 8 |
| Education | $19.84 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celltrion USA Inc. | $47.25 | 2 |
| Medtronic, Inc. | $46.37 | 1 |
| PFIZER INC. | $43.72 | 2 |
| Lilly USA, LLC | $31.14 | 1 |
| QOL Medical, LLC | $22.11 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.85 | 1 |
| ABBVIE INC. | $18.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.92 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105931332 | CMS |
| Celltrion USA Inc. | $19.84 | 05/06/2024 | Education | Undisputed | 01/23/2026 | 1075857131 | CMS |
| Celltrion USA Inc. | $27.41 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075857133 | CMS |
| Lilly USA, LLC | $31.14 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135020856 | CMS |
| Medtronic, Inc. | $46.37 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119516037 | CMS |
| PFIZER INC. | $22.39 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132055062 | CMS |
| PFIZER INC. | $21.33 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131019506 | CMS |
| QOL Medical, LLC | $22.11 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147725176 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.85 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137660878 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.